Stoke Therapeutics Eulerpool Новини

Stoke Therapeutics Новини за акции

Stoke Therapeutics се наблюдава от множество журналисти и инвеститори по целия свят. Най-актуалните Stoke Therapeutics новини събираме тук.

• 16 февруари ·

  SeekingAlpha
  Stoke Therapeutics: A Pivotal Moment For This RNA Pioneer
• 10 януари ·

  SeekingAlpha
  NervGen In Spotlight As It Approaches Clinical Proof Of Concept Readout For Spinal Cord Regeneration
• 8 януари ·

  Yahoo
  Tenvie raises $200M for brain drug R&D; Sana spikes on single patient’s results
• 7 януари ·

  Yahoo
  Stoke Therapeutics Announces Alignment with Global Regulatory Agencies and Plans to Initiate a Phase 3 Study of Zorevunersen as Potentially the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome
• 26 декември ·

  Yahoo
  The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex
• 17 декември ·

  Yahoo
  Companies Like Stoke Therapeutics (NASDAQ:STOK) Are In A Position To Invest In Growth
• 5 декември ·

  Yahoo
  STOK Shares Up on FDA's Breakthrough Tag for Dravet Syndrome Drug
• 4 декември ·

  Yahoo
  Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome
• 2 декември ·

  Yahoo
  Stoke Therapeutics Announces Plans to Present New Data that Support Zorevunersen as Potentially the First Disease-Modifying Medicine for Dravet Syndrome at the American Epilepsy Society 2024 Annual Meeting
• 26 ноември ·

  Yahoo
  An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond